Phreesia Current Liabilities
The Current Liabilities of Phreesia (PHR) as of Jul 25, 2026 is 133.72 M USD. In the previous year, Current Liabilities was 122.73 M USD — a change of 8.96% (higher).
Get this data via API
Financial Data API
Current Liabilities
133.72 MUSD
YoY
8.96%
Last updated:
Current Liabilities of Phreesia is 2026 133.72 M USD. Current Liabilities of Phreesia was 2025 122.73 M USD. It decreases by 8.96% higher compared to the previous year.
Access this data via the Eulerpool API
Phreesia Stock analysis
What does Phreesia do? Phreesia Inc is a US-based technology provider for healthcare companies that specializes in automating patient registrations and payments. The company was founded in 2005 by Chaim Indig and Evan Roberts and has since generated revenue of over $100 million.
The idea for Phreesia came from Indig and Roberts' frustrating experiences in healthcare company waiting rooms, where patients were burdened with tons of paperwork to fill out. They saw the need to automate processes around patient registrations and payments, to save both patients and healthcare providers time and energy.
Phreesia's business model is based on providing software and services that help healthcare companies electronically manage their patient registrations, payments, and communications. The company offers a wide range of products that include patient surveys, insurance information, consent forms, and payment processing. These products are delivered through the cloud-based Phreesia network, which healthcare companies can use to facilitate information exchange between patients and providers.
Over the years, Phreesia has developed a variety of divisions, including Phreesia Pulse, Phreesia Payments, and Phreesia Patient Connect. Each of these divisions focuses on different aspects of patient registration and payments, offering specific products and services.
Phreesia Pulse is one of Phreesia's key divisions and provides a platform for digital patient surveys. With this platform, healthcare companies can conduct digital surveys using tablets or other mobile devices to gather important information about the patient's medical history, symptoms, and other relevant medical data.
Phreesia Payments is another important division of Phreesia, offering a payment processing solution. By integrating payment processing into patient registration and communication, patients can make their payments directly through Phreesia, and healthcare providers can automatically send payment reminders via email or SMS.
Phreesia Patient Connect is an innovation that allows patients to connect with their doctor through Phreesia's patient portal. Through the portal, patients can view their medical information, schedule appointments, and communicate with their doctor.
Overall, Phreesia has experienced remarkable growth and success in the healthcare market. The company has received numerous awards, including the "Best in KLAS" award in the Patient Access category, as well as being named the "Fastest Growing Company in the Triad" by the Triad Business Journal.
Phreesia's business model has fundamentally changed and improved the way healthcare companies manage their patient administration and payments. Not only does Phreesia provide its customers with the necessary tools to automate the registration and payment information of their patients, but it also enables a higher level of patient satisfaction by enhancing information exchange and interaction through digital platforms.
As a leading healthcare technology provider, Phreesia will continue to stay true to its mission of developing innovative tools and services that improve the way healthcare companies care for their patients. Phreesia is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Phreesia stock
Current Liabilities of Phreesia is 133.72 M USD in 2026.
Access this data via the Eulerpool API
Balance Sheet — Phreesia
Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets
All Key Metrics — Phreesia
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth